Résultats de la recherche - 87 results

MRSA surveillance programmes worldwide: moving towards a harmonised international approach

Chabaud, Aurélie; Joanna Empel; Hege Enger; Hallin, Marie; Marina Ivanova; Andreas Kronenberg; Kuntaman, Kuntaman; Anders Rhod Larsen; Katrien Latour; Jodi A. Lindsay; Bruno Pichon; Dewi Santosaningsih; Leo ...

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015

Publication Type: Peer reviewed scientific article Authors: Katrien Latour; Huang, Te-Din; Beatrice Jans; Berhin, Catherine; Bogaerts, Pierre; Audrey Noel; Nonhoff, Claire; Magali Dodémont; Denis, ...

Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case–control study

trimethoprim/sulfamethoxazole (OR  = 1.56; 95% CI  = 1.23–1.97; P=0.00020) or nitrofurantoin (OR  = 1.50; 95% CI  = 1.23–1.84; P=0.000083). A sensitivity analysis excluding samples with antibiotic use during the 6 months prior ...

Surveillance of antimicrobial resistant bacteria in Belgian hospitals: report 2018

Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Katrien Latour; Goossens, H; Hallin, M; Huang, T D Source: Sciensano, Brussels, Belgium, p.57 (2020) ...

Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017

2016–17. Twenty-four European Union/European Economic Area (EU / EEA) countries, the former Yugoslav Republic of Macedonia and Serbia participated in the third PPS in European LTCF s. Overall, 4.9% (95% ...

Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017

Zingg; Pete Kinross; Klaus Weist; Dominique L. Monnet; Suetens, Carl; the Point Prevalence Survey Study Group; Katrien Latour; Eline Vandael Source: Eurosurveillance, Volume 23, Issue 46 (2018) Keywords: ...

Time trend of prevalence and susceptibility to nitrofurantoin of urinary MDR Escherichia coli from outpatients

OR 1.305; 95% CI 1.220-1.397). Within the MDR isolates, the prevalence of nitrofurantoin non-susceptibility decreased from 23.2% (623/2684) in 2005 to 10.7% (455/4253) in 2011-12 (adjusted OR 0.424; ...

QR code

QR code for this page URL